2-[(3R)-3-[(4-chloro-3-methylphenoxy)methyl]-1-(2,6-difluorobenzoyl)piperidin-3-yl]-1-piperidin-1-ylethanone
C27H31ClF2N2O3 — CID 124959001
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[(3R)-3-[(4-chloro-3-methylphenoxy)methyl]-1-(2,6-difluorobenzoyl)piperidin-3-yl]-1-piperidin-1-ylethanone
2-[(3R)-3-[(4-chloro-3-methylphenoxy)methyl]-1-(2,6-difluorobenzoyl)piperidin-3-yl]-1-piperidin-1-ylethanone (PubChem CID 124959001) has the molecular formula C27H31ClF2N2O3 and a molecular weight of 505.01 g/mol. Its IUPAC name is 2-[(3R)-3-[(4-chloro-3-methylphenoxy)methyl]-1-(2,6-difluorobenzoyl)piperidin-3-yl]-1-piperidin-1-ylethanone.
Molecular Properties
| Compound Name | 2-[(3R)-3-[(4-chloro-3-methylphenoxy)methyl]-1-(2,6-difluorobenzoyl)piperidin-3-yl]-1-piperidin-1-ylethanone |
|---|---|
| PubChem CID | 124959001 |
| Molecular Formula | C27H31ClF2N2O3 |
| Molecular Weight | 505.01 g/mol |
| Exact Mass | 504.20 |
| IUPAC Name | 2-[(3R)-3-[(4-chloro-3-methylphenoxy)methyl]-1-(2,6-difluorobenzoyl)piperidin-3-yl]-1-piperidin-1-ylethanone |
| SMILES | Cc1cc(OC[C@@]2(CC(=O)N3CCCCC3)CCCN(C(=O)c3c(F)cccc3F)C2)ccc1Cl |
| InChI | InChI=1S/C27H31ClF2N2O3/c1-19-15-20(9-10-21(19)28)35-18-27(16-24(33)31-12-3-2-4-13-31)11-6-14-32(17-27)26(34)25-22(29)7-5-8-23(25)30/h5,7-10,15H,2-4,6,11-14,16-18H2,1H3/t27-/m1/s1 |
| InChIKey | GJZBPUQMKHLRLM-HHHXNRCGSA-N |
| XLogP | 5.63 |
| TPSA | 49.85 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 505.01 |
| LogP ≤ 5 | 5.63 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 124959001 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.